Clinical Trial Update: Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial [Phase 2]

View source ↗

Summary

This document outlines a Phase 2 clinical trial (LAPP Trial) investigating the combination of lovastatin and pembrolizumab for recurrent or metastatic head and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Keytruda (Pembrolizumab) (pembrolizumab)
• Mevacor (lovastatin) (lovastatin)

Snippet

Sponsor: Emory University | Conditions: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary | Phase 2 | Status: RECRUITING